Pralidoxime
WHAT: Requirement for Pralidoxime for the treatment of Canadian Armed Forces members suspected of exposure to chemical warfare agents. Initial delivery of 450 doses required before 31 March 2027, with an option for an additional 600 doses to be delivered between 01 April 2027 and 31 March 2031. BUYE...
Read full summaryActions
Create a free account to analyze this opportunity, get daily notifications, and win more bids with Narwin.ai
Documents
Description
Read full description
NOTICE OF PROPOSED PROCUREMENT The Department of National Defence (DND) through the Strategic Medical Countermeasures Program on behalf of the Canadian Forces Health Services Group, has a requirement for Pralidoxime for the treatment of Canadian Armed Forces (CAF) members suspected of exposure to chemical warfare agents. The initial requirement is for the delivery of 450 doses to be delivered before 31 March 2027. Optional requirements of 600 doses to be requested and delivered between 01 April 2027 and 31 March 2031. There are no security requirements associated with this requirement. The Crown retains the rights to negotiate with suppliers on any procurement. Documents may be submitted in either official language of Canada. Policy on Reciprocal Procurement: This solicitation of offers is open only to Canadian suppliers (if subject to any international trade agreement(s)): and to Suppliers of an applicable trading partner.
Additional Information
Source
canadabuys
Status
open
Procurement Method
Competitive - Open bidding
Procurement Category
*GD
Selection Criteria
Lowest Price
Regions of Opportunity
*National Capital Region (NCR)
Regions of Delivery
*Foreign *Canada *Africa *Oceania *Unspecified *Remote Offsite *South America *Mexico *United States of America *World *Caribbean *Europe *Central America *North America *Aboriginal Lands *Asia
Reference Number
cb-572-47218385
Amendment Number
000
Contracting Entity
Department of National Defence (DND)
Contact Name
Stephen Brown
Contact Email
Contact Phone
+13436300031
Contact Country
Canada
Organization City
Ottawa
Organization Province / State
Ontario
Organization Country
Canada
Last Updated
September 25, 2026
Frequently Asked Questions
When is the proposal submission deadline?
The proposal submission deadline is November 10, 2026 (47 days left).
AI Summary
Read full summary
WHAT: Requirement for Pralidoxime for the treatment of Canadian Armed Forces members suspected of exposure to chemical warfare agents. Initial delivery of 450 doses required before 31 March 2027, with an option for an additional 600 doses to be delivered between 01 April 2027 and 31 March 2031.
BUYER: Department of National Defence (DND), Ottawa, Ontario, Canada. Contact: Stephen Brown ([email protected]).
GEOGRAPHY: Place of performance includes Canada and various international locations.
DATES: Posted on 2026-09-24; proposal due by 2026-11-10.
INDUSTRY/DOMAIN: Drugs and Pharmaceutical Products.
MANDATORY QUALS: Open only to Canadian suppliers and suppliers of applicable trading partners.
CONTRACT: Competitive - Open bidding.
Narwin.ai is a great way to find government contracts and opportunities. Disclaimer: This bid/tender/opportunity information is presented as is and may be incorrect at times. Please read the tender documents carefully before finalizing bids. We do not accept any responsibility and cannot be held legally liable for any inaccuracies.